Vivesto AB
(LTS:0N4A)
kr
0.3103
0 (0%)
Market Cap: 137.74 Mil
Enterprise Value: 59.98 Mil
PE Ratio: 0
PB Ratio: 0.77
GF Score: 40/100 Oasmia Pharmaceutical AB Online Presentation Transcript
Jan 19, 2022 / 01:00PM GMT
Release Date Price:
kr2.23
Klas Palin
Erik Penser Bank AB, Research Division - Research Analyst
Presentation
Jan 19, 2022 / 01:00PM GMT
=====================
Corporate Participants
=====================
* Francois R. Martelet
Oasmia Pharmaceutical AB (publ) - CEO
* Fredrik Jarrsten
Oasmia Pharmaceutical AB (publ) - CFO
=====================
Conference Call Participants
=====================
* Klas Palin
Erik Penser Bank AB, Research Division - Research Analyst
=====================
-
Francois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB
(foreign language) Francois, very welcome, and the floor is yours.
- ()-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot